https://www.selleckchem.com/pr....oducts/guggulsterone
25%) versus AT (21.61%; p = 0.418). Apixaban (15.7%; p 0.001) and rivaroxaban (13.19%; p = 0.011) were associated with lower rates of TBI, and acetylsalicylic acid-clopidogrel was associated with a higher TBI rate (24.34%; p = 0.002) versus no AT. acetylsalicylic acid-clopidogrel was associated with a higher cranial surgery rate (2.9%; p = 0.006) versus no AT (1.96%), but surgery rates were similar for all other regimens. No regimen was associated with higher mortality. In this large multicenter study, the intake of ATs in ol